In particular, data suggest the feasibility of determining a standard criterion whereby AD can be detected by examining total Tau alone with PKA phosphor-Tau sites (Ser214, Ser262, and Ser409) in CSF and the transient increase in phosphor-Tau by PKA but not GSK3β in CSF or iPSCs. Here, MAPT is linked to Alzheimer disease.